Exchange: NASDAQ·Updated 04:02 AM EDT
XFOR logo

XFOR X4 Pharmaceuticals Inc

$2.82
$0.01
(0.35%)
Pre-Market
Prev Close $2.83
EarningsNov 5
Mkt Cap$280.59M
Vol71.00

About XFOR

X4 Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and discovery of novel therapeutics for the treatment of rare diseases and those with limited treatment options. It is focused on mavorixafor which is being marketed in the U.S. under the trade name xolremdi. The company was founded by Henri A. Termeer, Keith T. Flaherty, Renato T. Skerlj, Richard Peters and Paula Ragan in 2010 and is headquartered in Boston, MA.
57

Bullish Sentiment

How do you feel about XFOR?

Advertisement|Remove ads.